nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—CYP2A6—Prednisolone—psoriatic arthritis	0.268	0.629	CbGbCtD
Ezogabine—CYP2A6—Dexamethasone—psoriatic arthritis	0.158	0.371	CbGbCtD
Ezogabine—Psychiatric symptom—Prednisone—psoriatic arthritis	0.036	0.0626	CcSEcCtD
Ezogabine—Dysphagia—Auranofin—psoriatic arthritis	0.0112	0.0195	CcSEcCtD
Ezogabine—Neutropenia—Auranofin—psoriatic arthritis	0.0105	0.0183	CcSEcCtD
Ezogabine—Haematuria—Auranofin—psoriatic arthritis	0.00954	0.0166	CcSEcCtD
Ezogabine—Visual impairment—Auranofin—psoriatic arthritis	0.00866	0.0151	CcSEcCtD
Ezogabine—Eye disorder—Auranofin—psoriatic arthritis	0.0084	0.0146	CcSEcCtD
Ezogabine—Alopecia—Auranofin—psoriatic arthritis	0.00794	0.0138	CcSEcCtD
Ezogabine—Raised liver function tests—Methotrexate—psoriatic arthritis	0.0075	0.0131	CcSEcCtD
Ezogabine—Leukopenia—Auranofin—psoriatic arthritis	0.007	0.0122	CcSEcCtD
Ezogabine—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00625	0.0109	CcSEcCtD
Ezogabine—Dyspepsia—Auranofin—psoriatic arthritis	0.00562	0.00978	CcSEcCtD
Ezogabine—Constipation—Auranofin—psoriatic arthritis	0.00546	0.0095	CcSEcCtD
Ezogabine—Encephalopathy—Methotrexate—psoriatic arthritis	0.0054	0.0094	CcSEcCtD
Ezogabine—Aphasia—Methotrexate—psoriatic arthritis	0.00534	0.0093	CcSEcCtD
Ezogabine—Memory impairment—Prednisone—psoriatic arthritis	0.00528	0.0092	CcSEcCtD
Ezogabine—Euphoric mood—Prednisolone—psoriatic arthritis	0.0049	0.00853	CcSEcCtD
Ezogabine—Euphoric mood—Triamcinolone—psoriatic arthritis	0.00451	0.00785	CcSEcCtD
Ezogabine—Euphoric mood—Methylprednisolone—psoriatic arthritis	0.0045	0.00783	CcSEcCtD
Ezogabine—Increased appetite—Prednisolone—psoriatic arthritis	0.00441	0.00767	CcSEcCtD
Ezogabine—Osteoarthritis—Prednisolone—psoriatic arthritis	0.00414	0.00721	CcSEcCtD
Ezogabine—Euphoric mood—Dexamethasone—psoriatic arthritis	0.00409	0.00712	CcSEcCtD
Ezogabine—Euphoric mood—Betamethasone—psoriatic arthritis	0.00409	0.00712	CcSEcCtD
Ezogabine—Increased appetite—Triamcinolone—psoriatic arthritis	0.00405	0.00706	CcSEcCtD
Ezogabine—Amnesia—Methylprednisolone—psoriatic arthritis	0.00404	0.00704	CcSEcCtD
Ezogabine—Increased appetite—Methylprednisolone—psoriatic arthritis	0.00404	0.00704	CcSEcCtD
Ezogabine—Rash—Auranofin—psoriatic arthritis	0.00402	0.00701	CcSEcCtD
Ezogabine—Dermatitis—Auranofin—psoriatic arthritis	0.00402	0.007	CcSEcCtD
Ezogabine—Skin discolouration—Methotrexate—psoriatic arthritis	0.00384	0.00668	CcSEcCtD
Ezogabine—Osteoarthritis—Triamcinolone—psoriatic arthritis	0.00381	0.00663	CcSEcCtD
Ezogabine—Osteoarthritis—Methylprednisolone—psoriatic arthritis	0.0038	0.00662	CcSEcCtD
Ezogabine—Nausea—Auranofin—psoriatic arthritis	0.00379	0.0066	CcSEcCtD
Ezogabine—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00371	0.00646	CcSEcCtD
Ezogabine—Increased appetite—Betamethasone—psoriatic arthritis	0.00368	0.0064	CcSEcCtD
Ezogabine—Increased appetite—Dexamethasone—psoriatic arthritis	0.00368	0.0064	CcSEcCtD
Ezogabine—Dysarthria—Methotrexate—psoriatic arthritis	0.00366	0.00638	CcSEcCtD
Ezogabine—Euphoric mood—Prednisone—psoriatic arthritis	0.00356	0.0062	CcSEcCtD
Ezogabine—Osteoarthritis—Betamethasone—psoriatic arthritis	0.00345	0.00602	CcSEcCtD
Ezogabine—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.00345	0.00602	CcSEcCtD
Ezogabine—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00337	0.00588	CcSEcCtD
Ezogabine—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00337	0.00588	CcSEcCtD
Ezogabine—Influenza—Triamcinolone—psoriatic arthritis	0.00329	0.00573	CcSEcCtD
Ezogabine—Weight increased—Prednisolone—psoriatic arthritis	0.00326	0.00567	CcSEcCtD
Ezogabine—Amnesia—Prednisone—psoriatic arthritis	0.0032	0.00558	CcSEcCtD
Ezogabine—Increased appetite—Prednisone—psoriatic arthritis	0.0032	0.00558	CcSEcCtD
Ezogabine—Coma—Methotrexate—psoriatic arthritis	0.00317	0.00551	CcSEcCtD
Ezogabine—Osteoarthritis—Prednisone—psoriatic arthritis	0.00301	0.00524	CcSEcCtD
Ezogabine—Weight increased—Triamcinolone—psoriatic arthritis	0.003	0.00521	CcSEcCtD
Ezogabine—Weight increased—Methylprednisolone—psoriatic arthritis	0.00299	0.0052	CcSEcCtD
Ezogabine—Psychotic disorder—Prednisone—psoriatic arthritis	0.00294	0.00512	CcSEcCtD
Ezogabine—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00293	0.0051	CcSEcCtD
Ezogabine—Infestation—Methylprednisolone—psoriatic arthritis	0.00293	0.0051	CcSEcCtD
Ezogabine—Visual impairment—Prednisolone—psoriatic arthritis	0.00276	0.00481	CcSEcCtD
Ezogabine—Weight increased—Betamethasone—psoriatic arthritis	0.00272	0.00473	CcSEcCtD
Ezogabine—Weight increased—Dexamethasone—psoriatic arthritis	0.00272	0.00473	CcSEcCtD
Ezogabine—Hallucination—Methylprednisolone—psoriatic arthritis	0.00262	0.00455	CcSEcCtD
Ezogabine—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00253	0.00441	CcSEcCtD
Ezogabine—Osteoarthritis—Methotrexate—psoriatic arthritis	0.00251	0.00438	CcSEcCtD
Ezogabine—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00246	0.00428	CcSEcCtD
Ezogabine—Neutropenia—Prednisone—psoriatic arthritis	0.00243	0.00423	CcSEcCtD
Ezogabine—Hallucination—Betamethasone—psoriatic arthritis	0.00238	0.00414	CcSEcCtD
Ezogabine—Hallucination—Dexamethasone—psoriatic arthritis	0.00238	0.00414	CcSEcCtD
Ezogabine—Weight increased—Prednisone—psoriatic arthritis	0.00237	0.00412	CcSEcCtD
Ezogabine—Vision blurred—Prednisolone—psoriatic arthritis	0.00235	0.00409	CcSEcCtD
Ezogabine—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00232	0.00404	CcSEcCtD
Ezogabine—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00231	0.00403	CcSEcCtD
Ezogabine—Visual impairment—Betamethasone—psoriatic arthritis	0.0023	0.00401	CcSEcCtD
Ezogabine—Visual impairment—Dexamethasone—psoriatic arthritis	0.0023	0.00401	CcSEcCtD
Ezogabine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.0023	0.00401	CcSEcCtD
Ezogabine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00229	0.00398	CcSEcCtD
Ezogabine—Malaise—Prednisolone—psoriatic arthritis	0.00225	0.00392	CcSEcCtD
Ezogabine—Vertigo—Prednisolone—psoriatic arthritis	0.00224	0.0039	CcSEcCtD
Ezogabine—Syncope—Prednisolone—psoriatic arthritis	0.00224	0.00389	CcSEcCtD
Ezogabine—Eye disorder—Betamethasone—psoriatic arthritis	0.00223	0.00389	CcSEcCtD
Ezogabine—Eye disorder—Dexamethasone—psoriatic arthritis	0.00223	0.00389	CcSEcCtD
Ezogabine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00219	0.00382	CcSEcCtD
Ezogabine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00213	0.0037	CcSEcCtD
Ezogabine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00212	0.0037	CcSEcCtD
Ezogabine—Alopecia—Dexamethasone—psoriatic arthritis	0.00211	0.00368	CcSEcCtD
Ezogabine—Alopecia—Betamethasone—psoriatic arthritis	0.00211	0.00368	CcSEcCtD
Ezogabine—Discomfort—Prednisolone—psoriatic arthritis	0.0021	0.00365	CcSEcCtD
Ezogabine—Hallucination—Prednisone—psoriatic arthritis	0.00207	0.00361	CcSEcCtD
Ezogabine—Malaise—Triamcinolone—psoriatic arthritis	0.00207	0.0036	CcSEcCtD
Ezogabine—Malaise—Methylprednisolone—psoriatic arthritis	0.00206	0.00359	CcSEcCtD
Ezogabine—Vertigo—Triamcinolone—psoriatic arthritis	0.00206	0.00359	CcSEcCtD
Ezogabine—Syncope—Triamcinolone—psoriatic arthritis	0.00206	0.00358	CcSEcCtD
Ezogabine—Vertigo—Methylprednisolone—psoriatic arthritis	0.00206	0.00358	CcSEcCtD
Ezogabine—Syncope—Methylprednisolone—psoriatic arthritis	0.00205	0.00357	CcSEcCtD
Ezogabine—Dysuria—Methotrexate—psoriatic arthritis	0.00203	0.00354	CcSEcCtD
Ezogabine—Neutropenia—Methotrexate—psoriatic arthritis	0.00203	0.00354	CcSEcCtD
Ezogabine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00202	0.00351	CcSEcCtD
Ezogabine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00201	0.0035	CcSEcCtD
Ezogabine—Shock—Prednisolone—psoriatic arthritis	0.002	0.00349	CcSEcCtD
Ezogabine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00197	0.00343	CcSEcCtD
Ezogabine—Eye disorder—Prednisone—psoriatic arthritis	0.00195	0.00339	CcSEcCtD
Ezogabine—Anxiety—Methylprednisolone—psoriatic arthritis	0.00194	0.00338	CcSEcCtD
Ezogabine—Infestation NOS—Methotrexate—psoriatic arthritis	0.00194	0.00337	CcSEcCtD
Ezogabine—Infestation—Methotrexate—psoriatic arthritis	0.00194	0.00337	CcSEcCtD
Ezogabine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00193	0.00336	CcSEcCtD
Ezogabine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00193	0.00336	CcSEcCtD
Ezogabine—Discomfort—Triamcinolone—psoriatic arthritis	0.00193	0.00336	CcSEcCtD
Ezogabine—Discomfort—Methylprednisolone—psoriatic arthritis	0.00192	0.00335	CcSEcCtD
Ezogabine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00191	0.00332	CcSEcCtD
Ezogabine—Confusional state—Methylprednisolone—psoriatic arthritis	0.00188	0.00328	CcSEcCtD
Ezogabine—Malaise—Betamethasone—psoriatic arthritis	0.00188	0.00327	CcSEcCtD
Ezogabine—Malaise—Dexamethasone—psoriatic arthritis	0.00188	0.00327	CcSEcCtD
Ezogabine—Vertigo—Betamethasone—psoriatic arthritis	0.00187	0.00325	CcSEcCtD
Ezogabine—Vertigo—Dexamethasone—psoriatic arthritis	0.00187	0.00325	CcSEcCtD
Ezogabine—Syncope—Betamethasone—psoriatic arthritis	0.00187	0.00325	CcSEcCtD
Ezogabine—Syncope—Dexamethasone—psoriatic arthritis	0.00187	0.00325	CcSEcCtD
Ezogabine—Infection—Triamcinolone—psoriatic arthritis	0.00186	0.00324	CcSEcCtD
Ezogabine—Infection—Methylprednisolone—psoriatic arthritis	0.00186	0.00323	CcSEcCtD
Ezogabine—Haematuria—Methotrexate—psoriatic arthritis	0.00185	0.00322	CcSEcCtD
Ezogabine—Shock—Triamcinolone—psoriatic arthritis	0.00184	0.00321	CcSEcCtD
Ezogabine—Alopecia—Prednisone—psoriatic arthritis	0.00184	0.0032	CcSEcCtD
Ezogabine—Shock—Methylprednisolone—psoriatic arthritis	0.00184	0.0032	CcSEcCtD
Ezogabine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00183	0.00319	CcSEcCtD
Ezogabine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00183	0.00319	CcSEcCtD
Ezogabine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00183	0.00318	CcSEcCtD
Ezogabine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00183	0.00318	CcSEcCtD
Ezogabine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00183	0.00318	CcSEcCtD
Ezogabine—Mental disorder—Prednisone—psoriatic arthritis	0.00182	0.00318	CcSEcCtD
Ezogabine—Malnutrition—Prednisone—psoriatic arthritis	0.00181	0.00315	CcSEcCtD
Ezogabine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00181	0.00315	CcSEcCtD
Ezogabine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00181	0.00314	CcSEcCtD
Ezogabine—Anxiety—Dexamethasone—psoriatic arthritis	0.00177	0.00307	CcSEcCtD
Ezogabine—Anxiety—Betamethasone—psoriatic arthritis	0.00177	0.00307	CcSEcCtD
Ezogabine—Discomfort—Dexamethasone—psoriatic arthritis	0.00175	0.00305	CcSEcCtD
Ezogabine—Discomfort—Betamethasone—psoriatic arthritis	0.00175	0.00305	CcSEcCtD
Ezogabine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00172	0.00299	CcSEcCtD
Ezogabine—Vision blurred—Prednisone—psoriatic arthritis	0.00171	0.00297	CcSEcCtD
Ezogabine—Urethral disorder—Methotrexate—psoriatic arthritis	0.00171	0.00297	CcSEcCtD
Ezogabine—Infection—Betamethasone—psoriatic arthritis	0.00169	0.00294	CcSEcCtD
Ezogabine—Infection—Dexamethasone—psoriatic arthritis	0.00169	0.00294	CcSEcCtD
Ezogabine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00168	0.00293	CcSEcCtD
Ezogabine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00168	0.00293	CcSEcCtD
Ezogabine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00168	0.00292	CcSEcCtD
Ezogabine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00168	0.00292	CcSEcCtD
Ezogabine—Visual impairment—Methotrexate—psoriatic arthritis	0.00168	0.00292	CcSEcCtD
Ezogabine—Shock—Betamethasone—psoriatic arthritis	0.00167	0.00291	CcSEcCtD
Ezogabine—Shock—Dexamethasone—psoriatic arthritis	0.00167	0.00291	CcSEcCtD
Ezogabine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00167	0.00291	CcSEcCtD
Ezogabine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00167	0.0029	CcSEcCtD
Ezogabine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00167	0.0029	CcSEcCtD
Ezogabine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00166	0.00289	CcSEcCtD
Ezogabine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00166	0.00289	CcSEcCtD
Ezogabine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00165	0.00287	CcSEcCtD
Ezogabine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00164	0.00286	CcSEcCtD
Ezogabine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00164	0.00286	CcSEcCtD
Ezogabine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00164	0.00286	CcSEcCtD
Ezogabine—Malaise—Prednisone—psoriatic arthritis	0.00163	0.00285	CcSEcCtD
Ezogabine—Vertigo—Prednisone—psoriatic arthritis	0.00163	0.00283	CcSEcCtD
Ezogabine—Eye disorder—Methotrexate—psoriatic arthritis	0.00163	0.00283	CcSEcCtD
Ezogabine—Syncope—Prednisone—psoriatic arthritis	0.00162	0.00283	CcSEcCtD
Ezogabine—Fatigue—Triamcinolone—psoriatic arthritis	0.00161	0.00281	CcSEcCtD
Ezogabine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00161	0.0028	CcSEcCtD
Ezogabine—Loss of consciousness—Prednisone—psoriatic arthritis	0.00159	0.00277	CcSEcCtD
Ezogabine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00154	0.00269	CcSEcCtD
Ezogabine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00154	0.00268	CcSEcCtD
Ezogabine—Anxiety—Prednisone—psoriatic arthritis	0.00154	0.00268	CcSEcCtD
Ezogabine—Alopecia—Methotrexate—psoriatic arthritis	0.00154	0.00268	CcSEcCtD
Ezogabine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00152	0.00265	CcSEcCtD
Ezogabine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00152	0.00265	CcSEcCtD
Ezogabine—Discomfort—Prednisone—psoriatic arthritis	0.00152	0.00265	CcSEcCtD
Ezogabine—Mental disorder—Methotrexate—psoriatic arthritis	0.00152	0.00265	CcSEcCtD
Ezogabine—Malnutrition—Methotrexate—psoriatic arthritis	0.00151	0.00264	CcSEcCtD
Ezogabine—Dyspepsia—Betamethasone—psoriatic arthritis	0.00149	0.0026	CcSEcCtD
Ezogabine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00149	0.0026	CcSEcCtD
Ezogabine—Infection—Prednisone—psoriatic arthritis	0.00147	0.00256	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00147	0.00255	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00147	0.00255	CcSEcCtD
Ezogabine—Fatigue—Dexamethasone—psoriatic arthritis	0.00146	0.00255	CcSEcCtD
Ezogabine—Fatigue—Betamethasone—psoriatic arthritis	0.00146	0.00255	CcSEcCtD
Ezogabine—Shock—Prednisone—psoriatic arthritis	0.00145	0.00253	CcSEcCtD
Ezogabine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00145	0.00253	CcSEcCtD
Ezogabine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00143	0.00249	CcSEcCtD
Ezogabine—Vision blurred—Methotrexate—psoriatic arthritis	0.00143	0.00248	CcSEcCtD
Ezogabine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00141	0.00245	CcSEcCtD
Ezogabine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.0014	0.00244	CcSEcCtD
Ezogabine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.0014	0.00244	CcSEcCtD
Ezogabine—Malaise—Methotrexate—psoriatic arthritis	0.00137	0.00238	CcSEcCtD
Ezogabine—Vertigo—Methotrexate—psoriatic arthritis	0.00136	0.00237	CcSEcCtD
Ezogabine—Leukopenia—Methotrexate—psoriatic arthritis	0.00136	0.00236	CcSEcCtD
Ezogabine—Dizziness—Prednisolone—psoriatic arthritis	0.00135	0.00234	CcSEcCtD
Ezogabine—Asthenia—Triamcinolone—psoriatic arthritis	0.00134	0.00234	CcSEcCtD
Ezogabine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00134	0.00233	CcSEcCtD
Ezogabine—Paraesthesia—Prednisone—psoriatic arthritis	0.00133	0.00231	CcSEcCtD
Ezogabine—Dyspepsia—Prednisone—psoriatic arthritis	0.0013	0.00227	CcSEcCtD
Ezogabine—Rash—Prednisolone—psoriatic arthritis	0.00128	0.00223	CcSEcCtD
Ezogabine—Dermatitis—Prednisolone—psoriatic arthritis	0.00128	0.00223	CcSEcCtD
Ezogabine—Fatigue—Prednisone—psoriatic arthritis	0.00127	0.00222	CcSEcCtD
Ezogabine—Discomfort—Methotrexate—psoriatic arthritis	0.00127	0.00222	CcSEcCtD
Ezogabine—Constipation—Prednisone—psoriatic arthritis	0.00126	0.0022	CcSEcCtD
Ezogabine—Confusional state—Methotrexate—psoriatic arthritis	0.00125	0.00217	CcSEcCtD
Ezogabine—Dizziness—Triamcinolone—psoriatic arthritis	0.00124	0.00215	CcSEcCtD
Ezogabine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00123	0.00215	CcSEcCtD
Ezogabine—Infection—Methotrexate—psoriatic arthritis	0.00123	0.00214	CcSEcCtD
Ezogabine—Feeling abnormal—Prednisone—psoriatic arthritis	0.00122	0.00212	CcSEcCtD
Ezogabine—Asthenia—Betamethasone—psoriatic arthritis	0.00122	0.00212	CcSEcCtD
Ezogabine—Asthenia—Dexamethasone—psoriatic arthritis	0.00122	0.00212	CcSEcCtD
Ezogabine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00121	0.00211	CcSEcCtD
Ezogabine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00121	0.00211	CcSEcCtD
Ezogabine—Nausea—Prednisolone—psoriatic arthritis	0.00121	0.0021	CcSEcCtD
Ezogabine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00119	0.00208	CcSEcCtD
Ezogabine—Rash—Triamcinolone—psoriatic arthritis	0.00118	0.00205	CcSEcCtD
Ezogabine—Dermatitis—Triamcinolone—psoriatic arthritis	0.00118	0.00205	CcSEcCtD
Ezogabine—Rash—Methylprednisolone—psoriatic arthritis	0.00118	0.00205	CcSEcCtD
Ezogabine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00118	0.00205	CcSEcCtD
Ezogabine—Dizziness—Dexamethasone—psoriatic arthritis	0.00112	0.00196	CcSEcCtD
Ezogabine—Dizziness—Betamethasone—psoriatic arthritis	0.00112	0.00196	CcSEcCtD
Ezogabine—Nausea—Triamcinolone—psoriatic arthritis	0.00111	0.00194	CcSEcCtD
Ezogabine—Paraesthesia—Methotrexate—psoriatic arthritis	0.00111	0.00193	CcSEcCtD
Ezogabine—Nausea—Methylprednisolone—psoriatic arthritis	0.00111	0.00193	CcSEcCtD
Ezogabine—Dyspnoea—Methotrexate—psoriatic arthritis	0.0011	0.00192	CcSEcCtD
Ezogabine—Somnolence—Methotrexate—psoriatic arthritis	0.0011	0.00191	CcSEcCtD
Ezogabine—Dyspepsia—Methotrexate—psoriatic arthritis	0.00109	0.00189	CcSEcCtD
Ezogabine—Rash—Dexamethasone—psoriatic arthritis	0.00107	0.00186	CcSEcCtD
Ezogabine—Rash—Betamethasone—psoriatic arthritis	0.00107	0.00186	CcSEcCtD
Ezogabine—Dermatitis—Dexamethasone—psoriatic arthritis	0.00107	0.00186	CcSEcCtD
Ezogabine—Dermatitis—Betamethasone—psoriatic arthritis	0.00107	0.00186	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00107	0.00186	CcSEcCtD
Ezogabine—Fatigue—Methotrexate—psoriatic arthritis	0.00107	0.00186	CcSEcCtD
Ezogabine—Asthenia—Prednisone—psoriatic arthritis	0.00106	0.00185	CcSEcCtD
Ezogabine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00102	0.00177	CcSEcCtD
Ezogabine—Nausea—Betamethasone—psoriatic arthritis	0.00101	0.00176	CcSEcCtD
Ezogabine—Nausea—Dexamethasone—psoriatic arthritis	0.00101	0.00176	CcSEcCtD
Ezogabine—Dizziness—Prednisone—psoriatic arthritis	0.000978	0.0017	CcSEcCtD
Ezogabine—Rash—Prednisone—psoriatic arthritis	0.000932	0.00162	CcSEcCtD
Ezogabine—Dermatitis—Prednisone—psoriatic arthritis	0.000932	0.00162	CcSEcCtD
Ezogabine—Asthenia—Methotrexate—psoriatic arthritis	0.000887	0.00154	CcSEcCtD
Ezogabine—Nausea—Prednisone—psoriatic arthritis	0.000878	0.00153	CcSEcCtD
Ezogabine—Dizziness—Methotrexate—psoriatic arthritis	0.000817	0.00142	CcSEcCtD
Ezogabine—Rash—Methotrexate—psoriatic arthritis	0.000779	0.00136	CcSEcCtD
Ezogabine—Dermatitis—Methotrexate—psoriatic arthritis	0.000779	0.00136	CcSEcCtD
Ezogabine—Nausea—Methotrexate—psoriatic arthritis	0.000734	0.00128	CcSEcCtD
